TAMPA, Fla. (WFLA) — A pharmaceutical company has issued a recall of hundreds of thousands of blood medication bottles over the presence of a carcinogenic compound, according to the FDA.

FDA enforcement reports stated that Teva Pharmaceuticals, which is based in New Jersey, issued a voluntary nationwide recall of over 500,000 bottles of Prazosin Hydrochloride capsules.

The medication is typically used for the treatment of high blood pressure and usually safe to take.

However, the FDA reported that 580,844 bottles could contain an excessive amount of N-nitroso Prazosin impurity C, which has been linked to cancer.

The affected lots are: • 1mg Prazosin Hydrochloride capsules: 181,659 bottles Code information: a) NDC 0093-4067-01: Lot # 3010544A and 3010545A, Exp Date: 10/2025; Lot # 301

See Full Page